Estimating HIV incidence and detection rates from surveillance data

被引:8
作者
Posner, SJ
Myers, L
Hassig, SE
Rice, JC
Kissinger, P
Farley, TA
机构
[1] Dept Hlth & Hosp, Louisiana Off Publ Hlth, HIV AIDS Program, New Orleans, LA USA
[2] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat, New Orleans, LA USA
[3] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA
[4] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Community Hlth Sci, New Orleans, LA USA
关键词
D O I
10.1097/01.ede.0000112215.19764.2b
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Markov models that incorporate HIV test information can increase precision in estimates of new infections and permit the estimation of detection rates. The purpose of this study was to assess the functioning of a Markov model for estimating new HIV infections and HIV detection rates in Louisiana using surveillance data. Methods: We expanded a discrete-time Markov model by accounting for the change in AIDS case definition made by the Centers for Disease Control and Prevention in 1993. The model was applied to quarterly HIV/AIDS surveillance data reported in Louisiana from 1981 to 1996 for various exposure and demographic subgroups. When modeling subgroups defined by exposure categories, we adjusted for the high proportion of missing exposure information among recent cases. We ascertained sensitivity to changes in various model assumptions. Results: The model was able to produce results consistent with other sources of information in the state. Estimates of new infections indicated a transition of the HIV epidemic. in Louisiana from (1) predominantly white men and men who have sex with men to (2) women, blacks, and high-risk heterosexuals. The model estimated that 61% of all HIV/AIDS cases were detected and reported by 1996, yet half of all HIV/non-AIDS cases were yet to be detected. Sensitivity analyses demonstrated that the model was robust to several uncertainties. Conclusions: In general, the methodology provided a useful and flexible alternative for estimating infection and detection trends using data from a U.S. surveillance program. Its use for estimating current infection will need further exploration to address assumptions related to newer treatments.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 58 条
[1]   THE USE OF HUMAN-IMMUNODEFICIENCY-VIRUS DIAGNOSIS INFORMATION IN MONITORING THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME EPIDEMIC [J].
AALEN, OO ;
FAREWELL, VT ;
DEANGELIS, D .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1994, 157 :3-16
[2]   New therapy explains the fall in AIDS incidence with a substantial rise in number of persons on treatment expected [J].
Aalen, OO ;
Farewell, VT ;
De Angelis, D ;
Day, NE ;
Gill, ON .
AIDS, 1999, 13 (01) :103-108
[3]  
Aalen OO, 1997, STAT MED, V16, P2191, DOI 10.1002/(SICI)1097-0258(19971015)16:19&lt
[4]  
2191::AID-SIM645&gt
[5]  
3.0.CO
[6]  
2-5
[7]   Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models [J].
Alioum, A ;
Leroy, V ;
Commenges, D ;
Dabis, F ;
Salamon, R .
EPIDEMIOLOGY, 1998, 9 (06) :605-612
[8]  
Amundsen E J, 2000, J Epidemiol Biostat, V5, P233
[9]  
[Anonymous], MORBIDITY MORTALITY
[10]  
BACCHETTI P, 1993, STAT SCI, V8, P82, DOI 10.1214/ss/1177010994